Fibromyalgia associated with repeated gadolinium contrast-enhanced MRI examinations.
Chronic pain
Contrast agents
Fibromyalgia syndrome
Gadolinium deposition
Magnetic resonance imaging
Toxicity
Journal
Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
18
10
2019
revised:
28
01
2020
accepted:
08
02
2020
entrez:
18
3
2020
pubmed:
18
3
2020
medline:
18
3
2020
Statut:
epublish
Résumé
We report a case of a fibromyalgia (FM) patient with an history of brain-cancer presenting signs and symptoms of gadolinium toxicity following repeated administrations of a macrocyclic contrast agent, Gadovist. In the present report, we provide evidence supporting the hypothesis of a causal relationship linking gadolinium deposition to a clinical manifestation of disease, namely fibromyalgia. We unravel a role for gadolinium in the still unknown etiology of fibromyalgia as a metal toxicity disorder. Contrast agents are routinely administered in a clinical context. It is thus possible that the patients are mistakenly believed to show complaint of their primary disease, whereas, in some instances, their symptoms are associated with gadolinium deposition.
Identifiants
pubmed: 32180856
doi: 10.1016/j.radcr.2020.02.002
pii: S1930-0433(20)30043-1
pmc: PMC7063147
doi:
Types de publication
Case Reports
Langues
eng
Pagination
534-541Informations de copyright
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Références
J Physiol. 1993 Sep;469:639-52
pubmed: 8271221
Metallomics. 2009 Nov;1(6):479-88
pubmed: 21305156
Chem Biol Interact. 2003 Jul 25;146(1):27-37
pubmed: 12902150
J Rheumatol. 2011 Jun;38(6):1113-22
pubmed: 21285161
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503
pubmed: 23040363
PLoS One. 2017 Feb 10;12(2):e0171704
pubmed: 28187173
Naunyn Schmiedebergs Arch Pharmacol. 1997 Jun;355(6):699-706
pubmed: 9205953
Radiology. 2018 Aug;288(2):416-423
pubmed: 29737947
Neuroradiology. 2004 Dec;46 Suppl 2:s201-7
pubmed: 15645153
Am J Physiol. 1990 Sep;259(3 Pt 1):C515-20
pubmed: 2169198
Curr Probl Diagn Radiol. 2019 May - Jun;48(3):220-223
pubmed: 29530452
Neuro Endocrinol Lett. 2013;34(6):559-65
pubmed: 24378456
Isr Med Assoc J. 2014 Dec;16(12):753-8
pubmed: 25630203
Neurology. 2017 Mar 21;88(12):1206-1208
pubmed: 28202695
J Biochem. 1984 Mar;95(3):661-9
pubmed: 6144674
Reumatismo. 2008 Jul-Sep;60 Suppl 1:15-24
pubmed: 18852905
Arthritis Rheum. 1990 Feb;33(2):160-72
pubmed: 2306288
Invest Radiol. 2019 Aug;54(8):453-463
pubmed: 31265439
Neuroradiology. 2019 May;61(5):535-544
pubmed: 30710184
Invest Radiol. 2016 Jul;51(7):447-53
pubmed: 26863577
Clin Neuroradiol. 2018 Jun;28(2):159-169
pubmed: 29523896
Chemosphere. 2014 Apr;100:194-9
pubmed: 24321333
J Magn Reson Imaging. 2009 Dec;30(6):1240-8
pubmed: 19938036
AJNR Am J Neuroradiol. 2015 Oct;36(10):1859-65
pubmed: 26294649
Invest Radiol. 2016 Oct;51(10):661-5
pubmed: 27548344
Magn Reson Imaging. 2016 Dec;34(10):1383-1390
pubmed: 27530966
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
Magn Reson Imaging. 2016 Dec;34(10):1377-1382
pubmed: 27697544
Radiology. 2015 Jun;275(3):772-82
pubmed: 25742194
J Gen Physiol. 1990 Apr;95(4):679-96
pubmed: 2159974
Invest Radiol. 2006 Mar;41(3):272-8
pubmed: 16481910
Magn Reson Imaging. 2016 Dec;34(10):1373-1376
pubmed: 27580520
Curr Opin Nephrol Hypertens. 2019 Mar;28(2):154-162
pubmed: 30531473
Neurotoxicology. 2010 Aug;31(4):391-8
pubmed: 20398695
Magn Reson Imaging. 2016 Oct;34(8):1078-80
pubmed: 27211256
Adv Ther. 2016 Jan;33(1):1-28
pubmed: 26809251
Med Hypotheses. 2019 Aug;129:109240
pubmed: 31371082
Clin J Pain. 2016 Sep;32(9):737-46
pubmed: 27022674
Environ Res. 2018 Feb;161:573-579
pubmed: 29245125
Sci Rep. 2018 Mar 13;8(1):4419
pubmed: 29535330
Invest Radiol. 2016 May;51(5):280-9
pubmed: 26953564
Invest Radiol. 2004 Mar;39(3):138-42
pubmed: 15076005
Neuroscience. 1982 Jul;7(7):1615-22
pubmed: 6289176